Cynthia M. Stonnington, M.D., has three main research interests:
Applying neuroimaging methods to predict cognitive decline, with a long-term goal of combining neuroimaging, genetic, neuropsychological and behavioral measures to focus interventions at a time where individuals are likely to benefit.
Exploring the neuropsychiatric underpinnings of psychosomatic illness
Identifying and testing interventions that can help patients to increase their resiliency in the face of illness or risk for illness
Dr. Stonnington's current research efforts involve applying machine learning to imaging and cognitive scores for the purpose of predicting cognitive decline; testing exercise and other socially engaging interventions to potentially curb cognitive decline in at-risk individuals; and exploring cognitive and emotional mechanisms associated with functional neurological symptoms and their treatment.